Articles in E-pub version are posted online ahead of regular printed publication.
-
Editorials
Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis
- Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
- DOI: 10.3350/cmh.2024.0482 [Epub ahead of print]
-
Correspondences
Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era
- Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
- DOI: 10.3350/cmh.2024.0472 [Epub ahead of print]
-
Special Topic
A New Korean Nomenclature for Steatotic Liver Disease
- Byoung Kuk Jang, Dae Won Jun, Sang Gyune Kim, Seung up Kim, Won Kim, Sung Won Lee, Ju Hyun Shim, Su Jong Yu
- DOI: 10.3350/cmh.2024.0467 [Epub ahead of print]
-
Reviews
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
- Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
- DOI: 10.3350/cmh.2024.0222 [Epub ahead of print]
-
Editorials
Engineering HBV-specific T cells for treatment of HBV-related HCC and HBV infection: past, present and future
- Antonio Bertoletti, Anthony T Tan
- DOI: 10.3350/cmh.2024.0469 [Epub ahead of print]
-
Reviews
Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
- Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
- DOI: 10.3350/cmh.2024.0246 [Epub ahead of print]
-
Original Articles
UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL
- Renyu Zhang, Can Li, Shuai Zhang, Lingmin Kong, Zekun Liu, Yixiao Guo, Ying Sun, Cong Zhang, Yule Yong, Jianjun Lv, Meng Lu, Man Liu, Dong Wu, Tianjiao Zhang, Haijiao Yang, Ding Wei, Zhinan Chen, Huijie Bian
- DOI: 10.3350/cmh.2024.0236 [Epub ahead of print]
-
Burden of Mortality from Hepatocellular Carcinoma and Biliary Tract Cancers by Race and Ethnicity and Sex in US, 2018-2023
- Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
- DOI: 10.3350/cmh.2024.0318 [Epub ahead of print]
-
Correspondences
Correspondence on Editorial regarding “Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease”
- Do Seon Song, Dong Joon Kim
- DOI: 10.3350/cmh.2024.0448 [Epub ahead of print]
-
Editorials
Macrophage ATG16L1: potential candidate for MASH treatment
- Junjie Yu
- DOI: 10.3350/cmh.2024.0443 [Epub ahead of print]
-
Letters to the Editor
MAFLD-related hepatocellular carcinoma in China: An increasing problem
- Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
- DOI: 10.3350/cmh.2024.0386 [Epub ahead of print]
-
Editorials
The impact of ischemia-free liver transplantation to improve the prognosis of recipients using functionally marginal liver grafts
- Ho Joong Choi
- DOI: 10.3350/cmh.2024.0426 [Epub ahead of print]
-
Metformin and Statins and their role in reducing Hepatocellular Carcinoma Risk: Randomized trials are needed
- Paul Y. Kwo
- DOI: 10.3350/cmh.2024.0425 [Epub ahead of print]
-
Meeting the challenges of HCC post SVR in the Post-DAA Era: A Path Forward
- Seren M. Gedallovich, Paul Y. Kwo
- DOI: 10.3350/cmh.2024.0418 [Epub ahead of print]
-
Ursolic acid: A promising therapeutic agent for MASLD via inhibition of SPP1-induced Th17 cell differentiation
- So Jung Kim, Jeongeun Hyun
- DOI: 10.3350/cmh.2024.0412 [Epub ahead of print]
-
Modified quick-SOFA score: can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?
- Simone Incicco, Salvatore Piano
- DOI: 10.3350/cmh.2024.0409 [Epub ahead of print]
-
Original Articles
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
- Juchul Hwang, Hyeyoung Hwang, Hyunjae Shin, Bo Hyun Kim, Seong Hee Kang, Jeong-Ju Yoo, Mi Young Choi, Dong eun Lee, Dae Won Jun, Yuri Cho
- DOI: 10.3350/cmh.2023.0384 [Epub ahead of print]
-
Correspondences
Correspondence on editorial regarding “Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?”
- Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
- DOI: 10.3350/cmh.2024.0394 [Epub ahead of print]
-
Original Articles
Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC
- Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du
- DOI: 10.3350/cmh.2024.0058 [Epub ahead of print]
-
Editorials
MAFLD Is A Ubiquitous Latent Cofactor in Viral- and Alcoholic-related Hepatocellular Carcinoma
- Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi
- DOI: 10.3350/cmh.2024.0372 [Epub ahead of print]
-
Correspondences
Correspondence on Editorial regarding “Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: a gateway to personalized medicine”
- Su Bin Lim, Hyo Jung Cho
- DOI: 10.3350/cmh.2024.0368 [Epub ahead of print]
-
Reply to Unlocking the future: machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- DOI: 10.3350/cmh.2024.0365 [Epub ahead of print]
-
Replys to Correspondence
Reply to correspondence: “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
- Eileen Laurel Yoon, Dae Won Jun
- DOI: 10.3350/cmh.2024.0360 [Epub ahead of print]
-
Letters to the Editor
Equivalent Prevalence and Progression of Chronic Kidney Disease in NAFLD and MASLD
- Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
- DOI: 10.3350/cmh.2024.0264 [Epub ahead of print]
-
Correspondences
Correspondence on Letter regarding “Liver Sinusoidal Endothelial Cell: An Important Yet Often Overlooked Player in the Liver Fibrosis”
- Jiaorong Qu, Le Wang, Xiaojiaoyang Li
- DOI: 10.3350/cmh.2024.0357 [Epub ahead of print]
-
Editorials
Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine
- Joseph C. Ahn, Ju Dong Yang
- DOI: 10.3350/cmh.2024.0348 [Epub ahead of print]
-
Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure
- Hae Lim Lee, Jeong Won Jang
- DOI: 10.3350/cmh.2024.0346 [Epub ahead of print]
-
Original Articles
Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction
- Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim
- DOI: 10.3350/cmh.2024.0060 [Epub ahead of print]
-
Editorials
Unlocking the Role of Liver Sinusoidal Endothelial Cells: Key Players in Liver Fibrosis
- Yasuko Iwakiri
- DOI: 10.3350/cmh.2024.0343 [Epub ahead of print]
-
Letters to the Editor
Changing from NAFLD to MASLD: Cumulative incidence of gallstones between patients with NAFLD and those with MASLD in Asia
- Shuhei Fukunaga, Tomoyuki Nakane, Michita Mukasa, Hidetoshi Takedatsu, Takumi Kawaguchi
- DOI: 10.3350/cmh.2024.0233 [Epub ahead of print]
-
Original Articles
Macrophage ATG16L1 expression suppresses MASH progression by promoting lipophagy
- Qi Wang, Qingfa Bu, Zibo Xu, Yuan Liang, Jinren Zhou, Yufeng Pan, Haoming Zhou, Ling Lu
- DOI: 10.3350/cmh.2024.0107 [Epub ahead of print]
-
Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study
- Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
- DOI: 10.3350/cmh.2024.0055 [Epub ahead of print]
-
Editorials
Unlocking the future: machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
- Junlong Dai, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
- DOI: 10.3350/cmh.2024.0327 [Epub ahead of print]
-
Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?
- Naoshi Nishida
- DOI: 10.3350/cmh.2024.0324 [Epub ahead of print]
-
Original Articles
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and the risk of hepatocellular carcinoma: a nationwide cohort study
- Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, Seulggie Choi, Sun Jae Park, Hye Jun Kim, Gyeongsil Lee, Joung Sik Son, Heejoon Jang, Dong Hyeon Lee, Meng Sha, Lei Chen, Won Kim, Sang Min Park
- DOI: 10.3350/cmh.2024.0145 [Epub ahead of print]
-
Replys to Correspondence
Complement Proteins and Liver Diseases: A Response to the Correspondence
- Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
- DOI: 10.3350/cmh.2024.0320 [Epub ahead of print]
-
Letters to the Editor
Functional cure of CHB encounters resmetirom
- Nai-Bin Yang, Wai-Kay Seto, Ming-Hua Zheng
- DOI: 10.3350/cmh.2024.0301 [Epub ahead of print]
-
Reviews
Unmet needs in the post-DAA era: the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication
- Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
- DOI: 10.3350/cmh.2024.0155 [Epub ahead of print]
-
Correspondences
Reply to: “Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization”
- Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu
- DOI: 10.3350/cmh.2024.0266 [Epub ahead of print]
-
Original Articles
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
- Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chi-Yi Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Wan-Long, Ming-Jong Bair, Ming-Lung Yu
- DOI: 10.3350/cmh.2024.0038 [Epub ahead of print]
-
Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis
- Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone Strasser, Jacob George
- DOI: 10.3350/cmh.2024.0109 [Epub ahead of print]
-
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease
- Yiyuan Zheng, Lina Zhao, Zhekun Xiong, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Yugang Fu, Simin Gu, Chong Chen, Jiacheng Li, Yingying Zhu, Jing Liu, Fengbin Liu, Yong Li
- DOI: 10.3350/cmh.2024.0047 [Epub ahead of print]
-
Replys to correspondence
Reply to correspondence regarding “Evaluation of the histological scoring systems for autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis”
- Atsumasa Komori
- DOI: 10.3350/cmh.2024.0242 [Epub ahead of print]
-
Replys to Correspondence
Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”
- Pin-Nan Cheng, Ming-Lung Yu
- DOI: 10.3350/cmh.2024.0228 [Epub ahead of print]
-
Original Articles
Ischemia-free liver transplantation improves the prognosis of recipients using Functioned Marginal Liver grafts
- Shuai Wang, Xiaohong Lin, Yunhua Tang, Yichen Liang, Min Zhang, Zhonghao Xie, Yiwen Guo, Yuqi Dong, Qiang Zhao, Zhiyong Guo, Dongping Wang, Xiaoshun He, Weiqiang Ju, Maogen Chen
- DOI: 10.3350/cmh.2024.0139 [Epub ahead of print]
-
Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
- Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
- DOI: 10.3350/cmh.2024.0103 [Epub ahead of print]
-
Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
- Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin
- DOI: 10.3350/cmh.2023.0563 [Epub ahead of print]
-
Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients
- Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery
- DOI: 10.3350/cmh.2023.0535 [Epub ahead of print]
-
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
- Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
- DOI: 10.3350/cmh.2024.0042 [Epub ahead of print]
-
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
- Young Eun Chon, Dong Yun Kim, Mina Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Yeonjung Ha, Joo Ho Lee, Kwan Sik Lee, Beodeul Kang, Jung Sun Kim, Hong Jae Chon, Do Young Kim
- DOI: 10.3350/cmh.2023.0553 [Epub ahead of print]
-
Letters to the Editor
Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
- Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
- DOI: 10.3350/cmh.2024.0157 [Epub ahead of print]
-
Snapshots
Examining the therapeutic landscape of beta-blockers in portal hypertension
- Anna Brujats, Càndid Villanueva
- DOI: 10.3350/cmh.2024.0144 [Epub ahead of print]
-
Reviews
Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
- Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li
- DOI: 10.3350/cmh.2024.0022 [Epub ahead of print]
-
Snapshots
Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
- DOI: 10.3350/cmh.2023.0555 [Epub ahead of print]